Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retrospective Cohort Study of Novel Oral Agents Lenalidomide and Duvelisib For Relapsed or Refractory Mycosis Fungoides and Sézary Syndrome.
Elghawy O, Yang AG, Sussman JH, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Villasenor-Park J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK. Elghawy O, et al. Among authors: villasenor park j. J Am Acad Dermatol. 2024 Nov 16:S0190-9622(24)03212-2. doi: 10.1016/j.jaad.2024.10.095. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39557080 No abstract available.
Cutaneous B-Cell Lymphomas.
Villasenor-Park J, Chung J, Kim EJ. Villasenor-Park J, et al. Hematol Oncol Clin North Am. 2024 Oct;38(5):1111-1131. doi: 10.1016/j.hoc.2024.05.017. Epub 2024 Jul 23. Hematol Oncol Clin North Am. 2024. PMID: 39048407 Review.
Usage and safety of topical tacrolimus in patients with mycosis fungoides.
Weiner DM, Clark AK, Bhansali RS, Pappas-Taffer L, Barta SK, Villasenor-Park J, Haun PL, Vittorio CC, Rook AH, Kim EJ, Samimi SS. Weiner DM, et al. Among authors: villasenor park j. Clin Exp Dermatol. 2022 Jun;47(6):1200-1201. doi: 10.1111/ced.15162. Epub 2022 Apr 1. Clin Exp Dermatol. 2022. PMID: 35245947 No abstract available.
Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome.
Lewis DJ, Haun PL, Samimi SS, Vittorio CC, Villasenor-Park J, Barta SK, Landsburg DJ, Svoboda J, Nasta SD, Schuster SJ, Rook AH, Kim EJ. Lewis DJ, et al. Among authors: villasenor park j. JAMA Dermatol. 2021 Mar 1;157(3):317-321. doi: 10.1001/jamadermatol.2020.4901. JAMA Dermatol. 2021. PMID: 33377934 Free PMC article.
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis.
Durgin JS, Jariwala NN, Wysocka M, Zhang KK, Maity A, Benoit B, Plastaras JP, Lewis DJ, Rosenthal JM, Teague JE, Berg S, Del Guzzo C, Kim EJ, Vittorio C, Haun PL, Samimi SS, Villasenor-Park J, Inverso J, Clark RA, Rook AH. Durgin JS, et al. Among authors: villasenor park j. JAMA Dermatol. 2021 Jan 1;157(1):90-95. doi: 10.1001/jamadermatol.2020.3958. JAMA Dermatol. 2021. PMID: 33112366 Free PMC article.
Tumor Stage Mycosis Fungoides in a Child.
Dulmage BO, Villaseñor-Park J, Ho J, Geskin LJ, Grandinetti LM. Dulmage BO, et al. Among authors: villasenor park j. Pediatr Dermatol. 2015 Jul-Aug;32(4):e156-8. doi: 10.1111/pde.12570. Epub 2015 Apr 17. Pediatr Dermatol. 2015. PMID: 25892093
Erosive plaques in the intertriginous regions of a woman.
Duerr E, Villaseñor-Park J, Grandinetti L. Duerr E, et al. Among authors: villasenor park j. JAMA Dermatol. 2014 Oct;150(10):1105-6. doi: 10.1001/jamadermatol.2014.1176. JAMA Dermatol. 2014. PMID: 25162987 No abstract available.
16 results